Home Nucleus Pharmaceuticals Norway Blood Plasma & Plasma Derived Medicinal Products Market to 2032

Norway Blood Plasma & Plasma Derived Medicinal Products Market to 2032

Overview

The Norway Blood Plasma & Plasma Derived Medicinal Products Market is expected to reach a 136.28 USD Million by 2032 and is projected to grow at a CAGR of 5.97% from 2025 to 2032.

Revenue, 2024 (USD Million)
86.07
Forecast, 2032 (USD Million)
136.28
CAGR, 2024 - 2032
5.97%
Report Coverage
Norway

Norway Blood Plasma & Plasma Derived Medicinal Products Market 2018-2032 USD Million

Norway Blood Plasma & Plasma Derived Medicinal Products Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 86.07 USD Million
  • Projected Market Size (2032): 136.28 USD Million
  • CAGR (2025-2032): 5.97%

Key Findings of Norway Blood Plasma & Plasma Derived Medicinal Products Market

  • The Norway Blood Plasma & Plasma Derived Medicinal Products Market was valued at 86.07 USD Million in 2024.
  • The Norway Blood Plasma & Plasma Derived Medicinal Products Market is likely to grow at a CAGR of 5.97% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Modern in Mode Segment accounted for the largest share of the market with a revenue of 63.69 USD Million
  • The fastest growing segment Immunology in Application Segment grew Fastest with a CAGR of 6.50% during the forecast period from 2024 to 2032.

Norway Blood Plasma & Plasma Derived Medicinal Products Market Scope

Norway Blood Plasma & Plasma Derived Medicinal Products Market Segmentation & Scope
Product
  • Monoclonal Antibodies (Derived from Plasma Cells)
  • Other Plasma Derived Proteins
  • Protease Inhibitors (For Genetic Deficiencies)
  • Albumin (Plasma Volume Expander)
  • Coagulation Factors (For Bleeding Disorders)
  • Immunoglobulins
Processing Technology
  • Microfiltration
  • Ultrafiltration
  • Cryoprecipitation
  • Affinity Chromatography
  • Ion Exchange Chromatography
Application
  • Rheumatology
  • Haemato-Oncology
  • Pulmonology
  • Other Applications
  • Neurology
  • Critical Care
  • Hematology
  • Immunology
Mode
  • Traditional Plasma Fractionation
  • Modern
End User
  • Academic Institutes
  • Others
  • Research Labs
  • Hospitals & Clinics
Distribution Channel
  • Others
  • Third Party Distributors
  • Direct Tenders

Norway Blood Plasma & Plasma Derived Medicinal Products Market Data Coverage Insights

Study Period 2024-2032
Base Year 2024
Unit Revenue in USD Million
Market Value in 2024 86.07 USD Million
Market Value in 2032 136.28 USD Million
CAGR (2025-2032) 5.97%
Historic Data 2016-2023
Market Segments Covered Product,Processing Technology,Application,Mode,End User,Distribution Channel

Regional Insights:

  • Leading Market (2024-2032): Norway, leading in terms of revenue 86.07 USD Million in 2024
    • Key Country: Norway, leading in terms of revenue with value of 86.07 USD Million in 2024.

Segments and Scope

  • Norway Blood Plasma & Plasma Derived Medicinal Products Market to 2032, By Product
    • Immunoglobulins is the largest segment in Norway Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a revenue of 36.30 USD Million in the year 2024.
    • Coagulation Factors (For Bleeding Disorders) is the Fastest growing segment in Norway Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a Growth rate of 6.03 % in forecast period 2025-2032.
  • Norway Blood Plasma & Plasma Derived Medicinal Products Market to 2032, By Processing Technology
    • Ion Exchange Chromatography is the largest segment in Norway Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a revenue of 26.43 USD Million in the year 2024.
    • Affinity Chromatography is the Fastest growing segment in Norway Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a Growth rate of 6.06 % in forecast period 2025-2032.
  • Norway Blood Plasma & Plasma Derived Medicinal Products Market to 2032, By Application
    • Immunology is the largest segment in Norway Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a revenue of 27.47 USD Million in the year 2024.
    • Immunology is the Fastest growing segment in Norway Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a Growth rate of 6.50 % in forecast period 2025-2032.
  • Norway Blood Plasma & Plasma Derived Medicinal Products Market to 2032, By Mode
    • Modern is the largest segment in Norway Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a revenue of 63.69 USD Million in the year 2024.
    • Modern is the Fastest growing segment in Norway Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a Growth rate of 6.08 % in forecast period 2025-2032.
  • Norway Blood Plasma & Plasma Derived Medicinal Products Market to 2032, By End User
    • Hospitals & Clinics is the largest segment in Norway Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a revenue of 58.03 USD Million in the year 2024.
    • Hospitals & Clinics is the Fastest growing segment in Norway Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a Growth rate of 6.18 % in forecast period 2025-2032.
  • Norway Blood Plasma & Plasma Derived Medicinal Products Market to 2032, By Distribution Channel
    • Direct Tenders is the largest segment in Norway Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a revenue of 43.95 USD Million in the year 2024.
    • Direct Tenders is the Fastest growing segment in Norway Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a Growth rate of 6.36 % in forecast period 2025-2032.

Norway Blood Plasma & Plasma Derived Medicinal Products Market Company Share Analysis

 
Company Name Company Share Analysis
Octapharma AG
Kedrion S.p.A
Takeda Pharmaceutical Company Limited
Grifols, S.A.
CSL
Norway Blood Plasma & Plasma Derived Medicinal Products Market Company Share Analysis

Norway Blood Plasma & Plasma Derived Medicinal Products Market Geographical Sales Distribution, 2018-2032 USD Million

Norway Blood Plasma & Plasma Derived Medicinal Products Market Geographical Sales Distribution, 2018-2032 USD Million

Norway Blood Plasma & Plasma Derived Medicinal Products Market Company Profiling

Norway Blood Plasma & Plasma Derived Medicinal Products Market Company Profiling

Industry Related Reports

South America Cold Sore Treatment Market
Middle East & Africa Cold Sore Treatment Market
North America Cold Sore Treatment Market
Europe Cold Sore Treatment Market
Asia-Pacific Cold Sore Treatment Market
Argentina Cold Sore Treatment Market
Australia Cold Sore Treatment Market
Austria Cold Sore Treatment Market
Belgium Cold Sore Treatment Market
Brazil Cold Sore Treatment Market
Frequently Asked Questions
The Norway Blood Plasma & Plasma Derived Medicinal Products Market is segmented based on Segmentation Product,Processing Technology,Application,Mode,End User,Distribution Channel.
Norway Blood Plasma & Plasma Derived Medicinal Products Market was valued at USD 86.07(Revenue in USD Million) in 2024.
Norway Blood Plasma & Plasma Derived Medicinal Products Market is projected to grow at a CAGR of 5.97% during the forecast period of 2024 to 2032.
The Modern segment is expected to dominate the Norway Blood Plasma & Plasma Derived Medicinal Products Market, holding a largest market share of 63.69 USD Million in 2024

Coming Soon....

Norway Blood Plasma & Plasma Derived Medicinal Products Market Scope

Norway Blood Plasma & Plasma Derived Medicinal Products Market Segmentation & Scope
Product
  • Monoclonal Antibodies (Derived from Plasma Cells)
  • Other Plasma Derived Proteins
  • Protease Inhibitors (For Genetic Deficiencies)
  • Albumin (Plasma Volume Expander)
  • Coagulation Factors (For Bleeding Disorders)
  • Immunoglobulins
Processing Technology
  • Microfiltration
  • Ultrafiltration
  • Cryoprecipitation
  • Affinity Chromatography
  • Ion Exchange Chromatography
Application
  • Rheumatology
  • Haemato-Oncology
  • Pulmonology
  • Other Applications
  • Neurology
  • Critical Care
  • Hematology
  • Immunology
Mode
  • Traditional Plasma Fractionation
  • Modern
End User
  • Academic Institutes
  • Others
  • Research Labs
  • Hospitals & Clinics
Distribution Channel
  • Others
  • Third Party Distributors
  • Direct Tenders
Frequently Asked Questions
The Norway Blood Plasma & Plasma Derived Medicinal Products Market is segmented based on Segmentation Product,Processing Technology,Application,Mode,End User,Distribution Channel.
Norway Blood Plasma & Plasma Derived Medicinal Products Market was valued at USD 86.07(Revenue in USD Million) in 2024.
Norway Blood Plasma & Plasma Derived Medicinal Products Market is projected to grow at a CAGR of 5.97% during the forecast period of 2024 to 2032.
The estimated market value of the Norway Blood Plasma & Plasma Derived Medicinal Products Market for final year is USD 136.28 (USD Million).

Norway Blood Plasma & Plasma Derived Medicinal Products Market Company Profiling

Norway Blood Plasma & Plasma Derived Medicinal Products Market Company Profiling
Frequently Asked Questions
The Norway Blood Plasma & Plasma Derived Medicinal Products Market is segmented based on Segmentation Product,Processing Technology,Application,Mode,End User,Distribution Channel.
Norway Blood Plasma & Plasma Derived Medicinal Products Market was valued at USD 86.07(Revenue in USD Million) in 2024.
Norway Blood Plasma & Plasma Derived Medicinal Products Market is projected to grow at a CAGR of 5.97% during the forecast period of 2024 to 2032.
The estimated market value of the Norway Blood Plasma & Plasma Derived Medicinal Products Market for final year is USD 136.28 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.